CIK: 0001858198
Total reported value
$133.9M
Reporting period: 2026-03-31 · Number of holdings: 32
KVP Capital Advisors, LP disclosed 32 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $133.9M and a quarterly turnover rate of 51.7%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "K"
KVP Capital Advisors, LP's disclosed holdings carry a Herfindahl concentration index of 0.063 — mathematically equivalent to about 16 equally-sized positions, well below its 32 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes are fairly uniform across the portfolio (a coefficient of variation of 1.03), suggesting a disciplined, rules-based approach to how much capital goes into each idea.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 13% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Trim PRAX
0.0% $1.2M
Trim AXSM
0.0% -$493.0K
Trim IRON
0.0% -$901.1K
Trim TVTX
0.0% -$773.5K
Trim TRVI
0.0% -$244.3K
Trim INSM
0.0% -$299.8K
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | 430 | Terns Pharmaceuticals INC | Stock-Other | 17.32% | +0.12% | — | |
| 2 | PRAX | Praxis Precision Medicines I | Stock-Other | 10.32% | -1.92% | — | |
| 3 | WHWK | Whitehawk Therapeutics INC | Stock-Other | 5.58% | +0.51% | — | |
| 4 | AXSM | Axsome Therapeutics INC | Stock-Healthcare | 4.57% | -1.83% | — | |
| 5 | STRO | Sutro Biopharma INC | Stock-Other | 4.22% | +4.22% | NEW | |
| 6 | PTGX | Protagonist Therapeutics INC | Stock-Other | 4.17% | -0.31% | — | |
| 7 | ERAS | Erasca INC | Stock-Other | 4.11% | +4.11% | NEW | |
| 8 | TRVI | Trevi Therapeutics INC | Stock-Other | 3.69% | -1.33% | — | |
| 9 | TNGX | Tango Therapeutics INC | Stock-Other | 3.60% | +3.60% | NEW | |
| 10 | INSM | Insmed INC | Stock-Healthcare | 3.48% | -1.32% | — | |
| 11 | EWTX | Edgewise Therapeutics INC | Stock-Other | 3.13% | -0.06% | — | |
| 12 | RVMD | Revolution Medicines INC | Stock-Healthcare | 2.92% | +0.80% | +46.18% | |
| 13 | IRON | Disc Medicine INC | Stock-Other | 2.78% | -1.70% | — | |
| 14 | MBX | Mbx Biosciences INC | Stock-Other | 2.71% | -1.00% | — | |
| 15 | SVRA | Savara INC | Stock-Other | 2.47% | -1.06% | — | |
| 16 | UTHR | United Therapeutics CORP | Stock-Healthcare | 2.10% | -0.14% | — | |
| 17 | TVTX | Travere Therapeutics INC | Stock-Other | 2.02% | -1.34% | — | |
| 18 | IDYA | Ideaya Biosciences INC | Stock-Other | 1.98% | +1.98% | NEW | |
| 19 | CMPX | Compass Therapeutics INC | Stock-Other | 1.98% | +1.98% | NEW | |
| 20 | OCUL | Ocular Therapeutix INC | Stock-Other | 1.90% | +1.90% | NEW | |
| 21 | VRDN | Viridian Therapeutics INC | Stock-Other | 1.83% | +1.83% | NEW | |
| 22 | DRUG | Bright Minds Biosciences INC | Stock-Other | 1.73% | +1.73% | NEW | |
| 23 | ✓ | Zura Bio LTD | Stock-Other | 1.66% | +1.66% | NEW | |
| 24 | SRRK | Scholar Rock Holding CORP | Stock-Other | 1.65% | -0.27% | — | |
| 25 | IMMX | Immix Biopharma INC | Stock-Other | 1.57% | +0.40% | — | |
| 26 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 1.49% | -1.18% | — | |
| 27 | NKTR | Nektar Therapeutics | Stock-Other | 1.45% | +0.35% | — | |
| 28 | CABA | Cabaletta Bio INC | Stock-Other | 1.02% | -0.05% | — | |
| 29 | ACHV | Achieve Life Sciences INC | Stock-Other | 1.02% | -1.20% | — | |
| 30 | VERA | Vera Therapeutics INC | Stock-Other | 0.98% | -0.62% | — | |
| 31 | CELC | Celcuity INC | Stock-Other | 0.34% | -0.05% | — | |
| 32 | VYNE | Vyne Therapeutics INC | Stock-Other | 0.22% | -0.06% | — |
Performance for Q3 2026
—
Performance Last 4 Quarters
—
Based on 0 months of available history
Based on 49% of reported portfolio value with available pricing
KVP Capital Advisors, LP's most significant position changes for 2026-03-31: New buy: Sutro Biopharma INC (STRO); New buy: Erasca INC (ERAS); Sold out: Jazz Pharmaceuticals PLC; New buy: Tango Therapeutics INC (TNGX); Sold out: Jazz Pharmaceuticals plc (JAZZ).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines INC | +0.8% | +46.18% | Add |
| 2 | WHWK | Whitehawk Therapeutics INC | +0.5% | — | Unchanged |
| 3 | IMMX | Immix Biopharma INC | +0.4% | — | Unchanged |
| 4 | NKTR | Nektar Therapeutics | +0.4% | — | Unchanged |
| 5 | 430 | Terns Pharmaceuticals INC | +0.1% | — | Unchanged |
| 6 | CABA | Cabaletta Bio INC | -0.1% | — | Unchanged |
| 7 | CELC | Celcuity INC | -0.1% | — | Unchanged |
| 8 | EWTX | Edgewise Therapeutics INC | -0.1% | — | Unchanged |
| 9 | VYNE | Vyne Therapeutics INC | -0.1% | — | Unchanged |
| 10 | UTHR | United Therapeutics CORP | -0.1% | — | Unchanged |
| 11 | SRRK | Scholar Rock Holding CORP | -0.3% | — | Unchanged |
| 12 | PTGX | Protagonist Therapeutics INC | -0.3% | — | Unchanged |
| 13 | VERA | Vera Therapeutics INC | -0.6% | — | Unchanged |
| 14 | MBX | Mbx Biosciences INC | -1% | — | Unchanged |
| 15 | SVRA | Savara INC | -1.1% | — | Unchanged |
| 16 | SLNOEUR | Soleno Therapeutics INC | -1.2% | — | Unchanged |
| 17 | ACHV | Achieve Life Sciences INC | -1.2% | — | Unchanged |
| 18 | INSM | Insmed INC | -1.3% | — | Unchanged |
| 19 | TRVI | Trevi Therapeutics INC | -1.3% | — | Unchanged |
| 20 | TVTX | Travere Therapeutics INC | -1.3% | — | Unchanged |
| 21 | IRON | Disc Medicine INC | -1.7% | — | Unchanged |
| 22 | AXSM | Axsome Therapeutics INC | -1.8% | — | Unchanged |
| 23 | PRAX | Praxis Precision Medicines I | -1.9% | — | Unchanged |
| 24 | STRO | Sutro Biopharma INC | — | NEW | New buy |
| 25 | ERAS | Erasca INC | — | NEW | New buy |
| 26 | ✓ | Jazz Pharmaceuticals PLC | — | EXIT | Sold out |
| 27 | TNGX | Tango Therapeutics INC | — | NEW | New buy |
| 28 | JAZZ | Jazz Pharmaceuticals plc | — | EXIT | Sold out |
| 29 | IDYA | Ideaya Biosciences INC | — | NEW | New buy |
| 30 | CMPX | Compass Therapeutics INC | — | NEW | New buy |
| 31 | OCUL | Ocular Therapeutix INC | — | NEW | New buy |
| 32 | VRDN | Viridian Therapeutics INC | — | NEW | New buy |
| 33 | DRUG | Bright Minds Biosciences INC | — | NEW | New buy |
| 34 | ✓ | Zura Bio LTD | — | NEW | New buy |
| 35 | ✓ | Fulcrum Therapeutics INC | — | EXIT | Sold out |
| 36 | FULC | Fulcrum Therapeutics INC | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-13 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-18 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001660328
Total reported value
$133.9M
42 stks
2026-06-30
AUM within 0.0% of this institution
CIK 0002084339
Total reported value
$133.8M
211 stks
2025-12-31
Stale — no recent filing
AUM within 0.1% of this institution
CIK 0001881590
Total reported value
$133.8M
601 stks
2024-12-31
Stale — no recent filing
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0001582844
Total reported value
$141.8M
27 stks
2026-03-31
3 of the top 5 holdings overlap, including Praxis Precision Medicines I
CIK 0001674712
Total reported value
$1.2B
46 stks
2026-03-31
2 of the top 5 holdings overlap, including Praxis Precision Medicines I
CIK 0001792126
Total reported value
$2.0B
66 stks
2026-03-31
2 of the top 5 holdings overlap, including Terns Pharmaceuticals INC